相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Remodeling domain interfaces to enhance heterodimer formation
Zhenping Zhu et al.
PROTEIN SCIENCE (2010)
Latest technologies for the enhancement of antibody affinity
Kim L. Wark et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments
Gregory Z. Ferl et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics
XY Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Improving the delivery of radionuclides for imaging and therapy of cancer using pretargeting methods
RM Sharkey et al.
CLINICAL CANCER RESEARCH (2005)
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: Biodistribution, pharmacokinetics, and quantitative tumor uptake
AM Scott et al.
CLINICAL CANCER RESEARCH (2005)
Domain interactions in the Fab fragment:: A comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability
D Röthlisberger et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Pharmacokinetics and biodistribution of 177Lu-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49
SC Chauhan et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
A diabody that dissociates to monomer forms at low concentration: effects on binding activity and tumor targeting
B Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The in vivo characteristics of genetically engineered divalent and tetravalent single-chain antibody constructs
UA Wittel et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
Arming antibodies: prospects and challenges for immunoconjugates
AM Wu et al.
NATURE BIOTECHNOLOGY (2005)
Engineered antibody fragments and the rise of single domains
P Holliger et al.
NATURE BIOTECHNOLOGY (2005)
Effect of linker sequences between the antibody variable domains on the formation, stability and biological activity of a bispecific tandem diabody
F Le Gall et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Tree-based model for breast cancer prognostication
M Banerjee et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Effect of tetravalent bispecific CD19 x CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells
U Reusch et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries
T Jostock et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications
T Olafsen et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Design of multivalent complexes using the barnase-barstar module
SM Deyev et al.
NATURE BIOTECHNOLOGY (2003)
Noncovalent scFv multimers of tumor-targeting anti-Lewisy hu3S193 humanized antibody
BE Power et al.
PROTEIN SCIENCE (2003)
Engineered antibodies
Peter J. Hudson et al.
NATURE MEDICINE (2003)
Pharmacokinetics and biodistribution of genetically engineered antibodies
SK Batra et al.
CURRENT OPINION IN BIOTECHNOLOGY (2002)
Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting
AA Kortt et al.
BIOMOLECULAR ENGINEERING (2001)
Design and application of diabodies, triabodies and tetrabodies for cancer targeting
A Todorovska et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Synthesis of high avidity antibody fragments (scFv multimers) for cancer imaging
BE Power et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2000)
分享论文
